ChanBio's Seed VC Round

ChanBio raised a round of funding on November 28, 2013. Investors include Merck Ventures.

ChanBio is a biopharmaceutical company dedicated to the development of functional antibody-based modulators active on ion channels and GPCRs, with the focus for treatment of autoimmune, cardiovascular…

Articles about ChanBio's Seed VC Round: